Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

TNM: evolution and relation to other prognostic factors.

Leslie H Sobin1

  • 1Department of Hepatic and Gastrointestinal Pathology, Armed Forces Institute of Pathology, Washington, DC 20306, USA. sobin@afip.osd.mil

Seminars in Surgical Oncology
|August 19, 2003
PubMed
Summary

The TNM Classification system for cancer staging has evolved over 50 years, improving accuracy with new diagnostic and treatment advances. Integrating non-anatomic prognostic factors presents a challenge for future cancer staging.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The histopathological classification, diagnosis and differential diagnosis of mucinous appendiceal neoplasms, appendiceal adenocarcinomas and pseudomyxoma peritonei.

Histopathology·2017
Same author

In Reply.

The American journal of surgical pathology·2016
Same author

A Consensus for Classification and Pathologic Reporting of Pseudomyxoma Peritonei and Associated Appendiceal Neoplasia: The Results of the Peritoneal Surface Oncology Group International (PSOGI) Modified Delphi Process.

The American journal of surgical pathology·2015
Same author

A Novel Approach to High-Quality Postmortem Tissue Procurement: The GTEx Project.

Biopreservation and biobanking·2015
Same author

Improving the TNM classification: findings from a 10-year continuous literature review.

International journal of cancer·2014
Same author

TNM seventh edition: what's new, what's changed: communication from the International Union Against Cancer and the American Joint Committee on Cancer.

Cancer·2010

Area of Science:

  • Oncology
  • Cancer Staging
  • Clinical Research

Background:

  • The TNM (Tumor, Node, Metastasis) Classification system is a cornerstone of cancer staging, detailing anatomic extent.
  • It differs from other systems by separately classifying T, N, and M components, aiding treatment planning, prognosis, and outcome evaluation.
  • The TNM system has continuously evolved over five decades, adapting to advancements in diagnostic imaging and therapeutic interventions.

Observation:

  • Advances such as endoscopic ultrasound have enhanced the accuracy of clinical T, N, and M classifications.
  • New treatment modalities and surgical techniques have led to refinements, including the "y" symbol for post-treatment staging, R classification for residual tumor, and the sentinel node (sn) symbol.
  • Immunohistochemistry has enabled the classification of isolated tumor cells and micrometastases, adding granularity to staging.

Related Experiment Videos

Findings:

  • The primary challenge lies in integrating numerous non-anatomic prognostic factors with the established anatomic TNM framework.
  • While TNM offers a foundation for prognostic classification, there's a risk of overwhelming the system with diverse data.
  • Effective methods are needed to combine TNM with non-anatomic factors for a comprehensive prognosis without compromising the integrity of the TNM system.

Implications:

  • The TNM Classification remains crucial for guiding initial treatment, patient stratification in clinical trials, and uniform communication of disease extent.
  • Developing methods to integrate non-anatomic prognostic factors is essential for a more holistic cancer prognosis.
  • Future approaches must balance the inclusion of new prognostic data with the preservation of TNM's distinct anatomic staging core.